نتایج جستجو برای: lipid lowering medications
تعداد نتایج: 232460 فیلتر نتایج به سال:
Series of clinical studies proved the beneficial effect lipid lowering therapy on process atherosclerosis and frequency cardiovascular events, according to these it plays an awarded role in preventive treatment recommendations. In most recent European dyslipidemia guidelines a lower LDL-cholesterol target has been established. Despite many evidence guidelines’ recommendations, quality lipid-low...
AIMS We sought to evaluate international patterns of use and factors influencing use of evidence-based medications early after ACS. METHODS AND RESULTS Using a database of 15904 ACS patients enrolled in the SYMPHONY and 2nd SYMPHONY trials in 37 countries, we performed descriptive and logistic regression analyses. After controlling for other factors, region was significantly associated with t...
Lipid-lowering medications have been shown to be efficacious, but adherence is suboptimal. This is a narrative, perspective review of recently published literature in the field of medication adherence research for lipid-lowering medications. We provide an overview of the impact of suboptimal adherence and use a World Health Organization framework (patient, condition, therapy, socioeconomic, and...
CONTEXT Although clinical trials have demonstrated the benefits of lipid-lowering therapy, little is known about how these drugs are prescribed or used in the general population. OBJECTIVE To estimate predictors of persistence with therapy for lipid-lowering drug regimens in typical populations of patients in the United States and Canada. DESIGN A cohort study defining all prescriptions fil...
ObjectiveTo validate self-reported use of medications for secondary prevention coronary heart disease (CHD) in a population-based health study by comparing self-report with pharmacy dispensing data, and explore different methods defining medication prescription databases.Study design settingSelf-reported among participants CHD (n = 1483) from the seventh wave Tromsø Study was linked Norwegian P...
Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively reduce fasting LDL cholesterol and triglycerides concentrations and several of them routinely reduce CVD risk. However, in contemporar...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید